Skip to main content
CTOR
NASDAQ Life Sciences

LYMPHIR Launch Gains Traction: 78% Jump in Ordering Institutions

Tom Rudovsky · Reported by PR Newswire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$0.635
Mkt Cap
$61.368M
52W Low
$0.491
52W High
$2.25
52W Position info
29% above low
Off High info
72% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

CTOR sits 29% above its 52-week low of $0.491.

Summary

Citius Oncology's LYMPHIR is showing real commercial momentum. New institutional accounts ordering the drug jumped 78% quarter-over-quarter, with total vial orders up 31%. The therapy is now in 42 institutions, and near-universal payer coverage removes a major access hurdle. This follows the June Phase 1 data presentation showing a 24% overall response rate for the LYMPHIR-pembrolizumab combo. With an expanded sales team now targeting over 250 priority centers and a goal of 100 formulary wins by year-end, the launch trajectory is accelerating. The initial CTCL market exceeds $400 million, and these early metrics suggest LYMPHIR is capturing share quickly.

At the time of this announcement, CTOR was trading at $0.63 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $61.4M. The 52-week trading range was $0.49 to $2.25. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

CTOR - Latest Insights

CTOR
Oct 26, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.588
Real-time Price: $0.5035 info
Change: -$0.0845 (-14%) info
Market Cap: $46.816M info
CTOR
Oct 23, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.5795
Real-time Price: $0.5035 info
Change: -$0.076 (-13%) info
Market Cap: $46.816M info
CTOR
Aug 14, 2026, 5:22 PM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $0.8399
Real-time Price: $0.5035 info
Change: -$0.3364 (-40%) info
Market Cap: $46.816M info
CTOR
Aug 14, 2026, 4:35 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.8862
Real-time Price: $0.5035 info
Change: -$0.3827 (-43%) info
Market Cap: $46.816M info
CTOR
Aug 14, 2026, 4:35 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.8862
Real-time Price: $0.5035 info
Change: -$0.3827 (-43%) info
Market Cap: $46.816M info